Dose-response Effects of a Recreational Team Handball-based Exercise Programme on Cardiovascular, Metabolic, Musculoskeletal and Physical Fitness Markers in Inactive Middle-aged and Older Male
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake
Study Overview
Brief Summary
The present study aims at analyzing the dose-response effects of a recreational team handball-based exercise programme on cardiovascular, metabolic, musculoskeletal and physical fitness markers of inactive middle-aged and older men, without previous experience with the sport. The researchers hypothesized a positive weekly training frequency effect on health and physical fitness outcomes.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 50 Years to 75 Years (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Male participants; inactive with 50 or more years of age (i.e., not complying with the physical activity guidelines for the last 6 months).
Exclusion Criteria
- •Any medical contraindication to perform moderate-to-vigorous physical activity; incapacity to run or grip a ball.
Arms & Interventions
Team Handball 1
Team handball group participants were instructed to perform one weekly 60-min recreational team handball training sessions for 16 weeks.
Intervention: Recreational Team Handball programme (Other)
Team Handball 2
Team handball group participants were instructed to perform two weekly 60-min recreational team handball training sessions for 16 weeks.
Intervention: Recreational Team Handball programme (Other)
Team Handball 3
Team handball group participants were instructed to perform three weekly 60-min recreational team handball training sessions for 16 weeks.
Intervention: Recreational Team Handball programme (Other)
Control Group
The control group participants were instructed to keep their regular daily physical activity for 16 weeks.
Outcomes
Primary Outcomes
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake
Time Frame: Baseline and week 16
Maximal oxygen uptake (mL/min/kg) was measured by pulmonary gas exchange measurements. The participants performed an incremental treadmill test until voluntary exhaustion in a laboratory, according to a standardized incremental protocol.
Secondary Outcomes
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral content(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in systolic blood pressure(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral density(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral density(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral content(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in diastolic blood pressure(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body lean mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral density(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral content(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in resting heart rate(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg lean mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg lean mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in carboxy-terminal type-1 collagen crosslinks(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in sclerostin(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total antioxidant status(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg total mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android fat mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm lean mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm lean mass(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total cholesterol(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in low-density lipoprotein cholesterol(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione peroxidase(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in procollagen type-1 amino-terminal propeptide(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in isometric upper body strength(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in triglycerides(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione reductase(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in postural balance(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in aerobic performance(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in high-density lipoprotein cholesterol(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glycosylated haemoglobin(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in osteocalcin(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in upper and lower body strength, and coordination(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glucose(Baseline and week 16)
- Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in insulin(Baseline and week 16)
Investigators
Susana Cristina Araújo Póvoas
Associate Professor
University Institute of Maia
